This is because Bacteroides Fragilis abundance in the microbiome, the source of the neurotoxin BF-LPS, can be regulated by dietary fibre intake.
The team concluded that further research on this connection could potentially lead to new diagnostic and therapeutic strategies in the clinical management of Alzheimer’s disease.
The gut microbiota is the scientific term for the microorganisms that live in the gut and comprises roughly 100 trillion organisms.
Together, these organisms play important roles in immunity, the digestion of food, metabolism, and neurological signalling, among other biological processes.
Previous analyses of the gut microbiome in people with Alzheimer’s disease have revealed a reduced diversity of microbes.
READ MORE: Dementia: Two types of humour associated with decline
